November 19, 2024

Analysis Maps Broad Semaglutide Eligibility

An estimated 136.8 million U.S. adults are eligible for semaglutide, a number exceeding current eligibility for statins, according to an analysis.

Conexiant

November 19, 2024

Lilly Pill Lowers Lp(a) Up to 86%: Study

Reuters

November 13, 2024

AHA/AAP Update Pediatric Drowning Response Protocols

When respiratory arrest is corrected by rescue breathing that interrupts the drowning process, the death rate is 44% compared to 93% when full CPR is needed—a stark difference highlighting the critical importance of early intervention in pediatric drowning cases.

Conexiant

November 12, 2024

Lp(a) and LDL-C: Separate ASCVD Risk Factors

Conexiant

November 12, 2024

New Data Links GLP-1s to Poststroke Outcomes

Post-stroke patients taking GLP-1 or SGLT2 medications showed a 74% lower mortality risk and 84% lower heart attack risk over 3 years compared to untreated peers.

Conexiant

November 12, 2024

CKM Could Mean Decades Earlier CVD Risk

Conexiant

November 11, 2024

Reducing Coronary Artery Disease Mortality with Stress Control

A recent review found that psychological stress management interventions reduced all-cause mortality by 37% in patients with coronary artery disease, while not showing a statistically significant effect on major adverse cardiovascular events (MACE) reduction.

Conexiant

November 05, 2024

High COVID-19 Burden Linked to More Hospital AEs

A recent study found a large increase in hospital adverse events during weeks with a high COVID-19 burden, with the impact hitting both COVID-19 and non-COVID-19 patients.

Conexiant

November 04, 2024

FTC Finalizes "Click-to-Cancel" Rule

FTC finalizes rule requiring subscription-based businesses to provide cancellation processes as simple as enrollment methods, effective 180 days after Federal Register publication.

Conexiant